| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Ethics > Business Ethics-What's Happening Where We Work? |
|
Main Subject - Business Ethics-What's Happening Where We Work?
The National Business Ethics Survey (NBES) provides an overview of ethics in the workplace and the 2005 version indicates that ethical misconduct is increasing. According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product And this is after Enron, et al. The NBES included more than 3,000 American workers and their survey showed that more than half of American workers have observ ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in d at least one type of ethical misconduct in the workplace. Yet, employee reporting of the misconduct they observe is down by 10%. This is cause for alarm, in lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. my opinion, and more businesses need to be aware of what is happening with ethics at work today. The NBES defines misconduct as “any behavior that violates the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe law or organizational ethics standards.” And the two most common types of misconduct observed by employees are abusive or intimidating behavior towards employee d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro and lying to employees, customers, vendors, or the public. The 2005 survey shows that types of misconduct most observed by employees include: 21% observe ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc abusive or intimidating behavior towards employees 19% observed lying to employees, customers, vendors, or the public. 18% observed a situation that easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi places employee interests over organizational interests. 16% observed violations of safety regulations. 12% observed discrimination on the basis of ra nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e, color, gender, age or similar categories. 11% observed stealing or theft. 9% observed sexual harassment. It is interesting to view these results k and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ owing that there has been regulation and other actions put in place since Enron and other corporate scandals. Ad although there has been an increased or renewe ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi emphasis on corporate ethics, there is not solid evidence of a positive direct impact on ethical behavior in the workplace. Organizations have received yet an ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ther “wake-up call” about ethics and need to evaluate what they are doing and look at the ethics culture within their companies. The bottom line is to find out dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod what formal program will work for them. A recommended formal ethics and compliance program, suggested by the Federal Sentencing Guidelines for Organizations, i cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin cludes six (6) elements. Those elements are: 1. Written standards of conduct 2. Training on ethics 3. Mechanisms to seek ethics advice or inf tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ormation 4. Means to report misconduct anonymously 5. Discipline of employees who violate ethical standards 6. Evaluation of employee’s perfor t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ance based on ethical conduct Ownership and senior management must recognize the problem and the risk factors and then develop and implement a strong ethics pr ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust gram within the organization. A strong ethical environment must be a top priority and the owners and senior management must lead by example and create a strong y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ethical culture throughout the company. Good corporate ethics needs to be what is happening in your workplace. If you are interested in learning more about th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de importance of business ethics and incorporating business ethics more deeply into your company culture, please contact Glenn Ebersole through his website at elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip REF="http://www.businesscoach4u.com" TARGET="_blank">http://www.businesscoach4u.com or email Glenn at jgecoach@aol.com tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Communicating with Your Residential Cleaning Clients is Key Top Career Advice ... More Choices and A Better Way of Life
|